Targeting the NLRP3 inflammasome has been shown to mitigate renal inflammation and improve kidney function in diabetic models, suggesting that inhibiting pyroptosis could represent a novel therapeutic approach for DKD [74]. This evidence concerns the gene NLRP3 and diabetic kidney disease.